tiprankstipranks
Revolution Medicines price target raised to $72 from $64 at H.C. Wainwright
The Fly

Revolution Medicines price target raised to $72 from $64 at H.C. Wainwright

H.C. Wainwright raised the firm’s price target on Revolution Medicines (RVMD) to $72 from $64 and keeps a Buy rating on the shares. The analyst believes the RMC-6236 Phase 1 data “risk-mitigate” the ongoing RASolute 302 trial and planned RASolve 301 trial. It is encouraged by the initial combination results.

Maximize Your Portfolio with Data Driven Insights:

  • Leverage the power of TipRanks' Smart Score, a data-driven tool to help you uncover top performing stocks and make informed investment decisions.
  • Monitor your stock picks and compare them to top Wall Street Analysts' recommendations with Your Smart Portfolio

Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>

Looking for investment ideas? Subscribe to our Smart Investor newsletter for weekly expert stock picks!
Get real-time notifications on news & analysis, curated for your stock watchlist. Download the TipRanks app today! Get the App